Furthermore, Fos-related antigen 1 (Fra-1) and Fos-related antigen 2 (Fra-2) prevent dietary NAFLD by blocking prostate PPAR signaling, demonstrating that hepatocyte-specific Fra-1 expression can successfully reverse established NAFLD and associated liver damage [47]. Here, FOSL2 is linked to metabolic dysfunction-associated steatotic liver disease.